e-therapeutics (LON:ETX) Trading 1.1% Higher

e-therapeutics plc (LON:ETX) rose 1.1% during mid-day trading on Tuesday . The company traded as high as GBX 11.22 ($0.14) and last traded at GBX 9.60 ($0.12). Approximately 948,419 shares were traded during trading, an increase of 31% from the average daily volume of 722,249 shares. The stock had previously closed at GBX 9.50 ($0.12).

e-therapeutics Trading Up 1.6 %

The company has a market capitalization of £56.39 million, a PE ratio of -475.00 and a beta of 0.48. The company has a debt-to-equity ratio of 0.33, a current ratio of 22.20 and a quick ratio of 20.13. The company’s fifty day moving average is GBX 11.35 and its 200-day moving average is GBX 11.77.

e-therapeutics Company Profile

e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet.